moclobemide (Q421934): Difference between revisions

From Wikidata

Jump to navigation Jump to search

Browse history interactively

← Older editNewer edit →

Revision as of 13:29, 6 December 2023 (restore) TiagoLubianaBot (talk | contribs) Bots 792,850 edits ‎Updated Item: Added drug-drug interaction. ← Older edit		Revision as of 13:29, 6 December 2023 (restore) undo TiagoLubianaBot (talk | contribs) Bots 792,850 edits ‎Updated Item: Added drug-drug interaction. Newer edit →
		Property / significant drug interaction
			cimetidine
		Property / significant drug interaction: cimetidine / rank
			Normal rank
		Property / significant drug interaction: cimetidine / qualifier
			side effect: tachycardia
		Property / significant drug interaction: cimetidine / reference
			sourcing circumstances: hypothetically stated in: A reference set of clinically relevant adverse drug-drug interactions

---

Revision as of 13:29, 6 December 2023

chemical compound

• GNF-Pf-695
• Manerix®
• Moclobemid
• Moclobemide
• Moclamine
• 4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide
• 4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide
• 4-Chlor-N-(2-morpholinoethyl)benzamid
• p-Chloro-N-(2-morpholinoethyl)benzamide
• Moclaime
• Moclamide
• Moclobemida
• Aurorix
• Moclobemidum

Language	Label	Description	Also known as
English	moclobemide	chemical compound	GNF-Pf-695 Manerix® Moclobemid Moclobemide Moclamine 4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide 4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide 4-Chlor-N-(2-morpholinoethyl)benzamid p-Chloro-N-(2-morpholinoethyl)benzamide Moclaime Moclamide Moclobemida Aurorix Moclobemidum

Statements

instance of

type of chemical entity

0 references

subclass of

chemical compound

0 references

has use

medication

0 references

chemical structure

4-chloro-N-(2-morpholinoethyl)benzamide 200.svg
276 × 113; 5 KB

0 references

mass

268.097855 dalton

1 reference

stated in

PubChem

PubChem CID

4235

language of work or name

English

title

moclobemide (English)

retrieved

3 October 2016

chemical formula

C₁₃H₁₇ClN₂O₂

1 reference

stated in

PubChem

PubChem CID

4235

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

canonical SMILES

C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl

1 reference

stated in

PubChem

PubChem CID

4235

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

defined daily dose

0.3 gram

route of administration

oral administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N06AG02

World Health Organisation international non-proprietary name

moclobemide (English)

1 reference

stated in

ChEBI

ChEBI ID

83531

language of work or name

English

title

moclobemide (English)

retrieved

3 October 2016

significant drug interaction

(+)-pseudoephedrine

side effect

hypertensive crisis

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

methyl (S)-phenyl[(S)-piperidin-2-yl]acetate

side effect

hypertensive crisis

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

phenylephrine

side effect

hypertensive crisis

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

bupropion

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

pethidine

side effect

toxicity

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

tramadol

side effect

toxicity

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

imipramine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

imipramine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

imipramine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

imipramine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sumatriptan

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sumatriptan

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sumatriptan

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

sumatriptan

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

frovatriptan

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

frovatriptan

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

frovatriptan

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

frovatriptan

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

phenylephrine

side effect

increased systemic arterial blood pressure

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(+)-pseudoephedrine

side effect

hyperpyrexia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(+)-pseudoephedrine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(+)-pseudoephedrine

side effect

headache disorder

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(−)-selegiline

side effect

hypertensive crisis

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

tachycardia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

vortioxetine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

side effect

tachycardia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

paroxetine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

tachycardia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluvoxamine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

side effect

tachycardia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

fluoxetine

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

side effect

hypertension

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

side effect

tachycardia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

side effect

mental status change

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

side effect

hyperthermia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

side effect

geniospasm

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

methyl (S)-phenyl[(S)-piperidin-2-yl]acetate

side effect

muscle stiffness

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

methyl (S)-phenyl[(S)-piperidin-2-yl]acetate

side effect

palpitation

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

methyl (S)-phenyl[(S)-piperidin-2-yl]acetate

side effect

headache disorder

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

toxic encephalopathy

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

seizure

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

geniospasm

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

mental status change

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

hyperthermia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

side effect

hypertension

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

sertraline

side effect

toxic encephalopathy

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

sertraline

side effect

mental status change

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

sertraline

side effect

geniospasm

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

sertraline

side effect

hyperthermia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

sertraline

side effect

hypertension

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

toxic encephalopathy

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

mental status change

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

geniospasm

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

hyperthermia

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

side effect

hypertension

1 reference

sourcing circumstances

probably

stated in

A reference set of clinically relevant adverse drug-drug interactions

cimetidine

side effect

tachypnea

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

cimetidine

side effect

anxiety

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

cimetidine

side effect

tachycardia

1 reference

sourcing circumstances

hypothetically

stated in

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Monoamine oxidase A

subject has role

enzyme inhibitor

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7428

language of work or name

English

retrieved

17 August 2016

Monoamine oxidase B

subject has role

enzyme inhibitor

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7428

language of work or name

English

retrieved

17 August 2016

pregnancy category

Australian pregnancy category B3

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

antidepressant

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

D020912

retrieved

15 March 2018

monoamine oxidase inhibitor

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

D020912

retrieved

15 March 2018

Commons category

Moclobemide

0 references

Identifiers

InChI

InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)

1 reference

stated in

PubChem

PubChem CID

4235

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

InChIKey

YHXISWVBGDMDLQ-UHFFFAOYSA-N

2 references

stated in

PubChem

PubChem CID

4235

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

stated in

ChEBI release 2020-09-01

CAS Registry Number

71320-77-9

2 references

stated in

Global Substance Registration System

UNII

PJ0Y7AZB63

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

stated in

CAS Common Chemistry

retrieved

7 April 2021

reference URL

https://commonchemistry.cas.org/detail?cas_rn=71320-77-9

InChIKey

YHXISWVBGDMDLQ-UHFFFAOYSA-N

ChemSpider ID

4087

1 reference

stated in

ChemSpider

ChemSpider ID

4087

language of work or name

English

title

Moclobemide (English)

retrieved

19 November 2016

PubChem CID

4235

1 reference

stated in

PubChem

PubChem CID

4235

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

Reaxys registry number

530974

1 reference

stated in

ChEBI

ChEBI ID

83531

language of work or name

English

title

moclobemide (English)

retrieved

3 October 2016

ChEBI ID

83531

mapping relation type

exact match

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL86304

language of work or name

English

title

MOCLOBEMIDE (English)

retrieved

19 November 2016

ChEMBL ID

CHEMBL86304

1 reference

stated in

ChEMBL

ChEMBL ID

CHEMBL86304

language of work or name

English

title

MOCLOBEMIDE (English)

retrieved

19 November 2016

UniChem compound ID

111369

1 reference

stated in

UniChem

MassBank accession ID

MSBNK-Athens_Univ-AU227901

0 references

MSBNK-Athens_Univ-AU227902

0 references

MSBNK-Athens_Univ-AU227903

0 references

MSBNK-Athens_Univ-AU227904

0 references

MSBNK-Athens_Univ-AU227905

0 references

MSBNK-Athens_Univ-AU227906

0 references

MSBNK-Athens_Univ-AU227957

0 references

MSBNK-Athens_Univ-AU227958

0 references

MSBNK-Eawag-EA267501

0 references

MSBNK-Eawag-EA267502

0 references

MSBNK-Eawag-EA267503

0 references

MSBNK-Eawag-EA267504

0 references

MSBNK-Eawag-EA267505

0 references

MSBNK-Eawag-EA267506

0 references

MSBNK-Eawag-EA267507

0 references

MSBNK-Eawag-EA267508

0 references

MSBNK-Eawag-EA267509

0 references

MSBNK-Eawag-EA267510

0 references

MSBNK-Eawag-EA267511

0 references

MSBNK-Eawag-EA267512

0 references

MSBNK-Eawag-EA267513

0 references

MSBNK-Eawag-EA267514

0 references

MSBNK-Waters-WA002051

0 references

MSBNK-Waters-WA002052

0 references

MSBNK-Waters-WA002053

0 references

MSBNK-Waters-WA002054

0 references

MSBNK-Waters-WA002055

0 references

MSBNK-Waters-WA002056

0 references

SPLASH

splash10-014i-0090000000-ebaa843d45c4c64c1d3d

0 references

splash10-00lr-0970000000-ab2fbe8b1feae9ff3141

0 references

splash10-001i-0900000000-e3243f45e1029a4c0e71

0 references

splash10-001i-0900000000-927950435244f3ac04e4

0 references

splash10-000i-0900000000-6fe640038cbc911e2bae

0 references

splash10-000i-0900000000-26e37ce9ba0b814b7409

0 references

splash10-014i-0090000000-07e0ca3dba489a2810ec

0 references

splash10-00lr-0980000000-70103607e1e68c966be9

0 references

splash10-001i-0900000000-ac7d3f04849dde0da3d2

0 references

splash10-001r-0900000000-6634fb6b07312ce02ee6

0 references

splash10-000i-0900000000-c43f4a856e6d225766ef

0 references

splash10-000i-0900000000-1231bd387729155af4ab

0 references

splash10-001i-0900000000-a885de4ee2be84e3748d

0 references

splash10-00lr-0950000000-2942178c074461702181

0 references

splash10-0udi-2900000000-c3230d46878446405991

0 references

HSDB ID

7180

1 reference

stated in

Hazardous Substances Data Bank

HSDB ID

7180

publication date

28 October 2019

title

MOCLOBEMIDE (English)

retrieved

10 May 2021

DSSTox substance ID

DTXSID9040554

1 reference

stated in

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

DTXCID7020554

0 references

EC number

636-108-5

1 reference

stated in

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.163.935

retrieved

27 December 2018

title

4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide (English)

quotation

CAS no.: 71320-77-9 (English)

ECHA Substance Infocard ID

100.163.935

1 reference

stated in

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.163.935

retrieved

27 December 2018

title

4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide (English)

quotation

CAS no.: 71320-77-9 (English)

ATC code

N06AG02

1 reference

stated in

DrugBank

DrugBank ID

01171

language of work or name

English

title

Moclobemide (English)

publication date

17 November 2015

Guide to Pharmacology Ligand ID

7428

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7428

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

MeSH descriptor ID

D020912

1 reference

stated in

Medical Subject Headings

MeSH descriptor ID

D020912

retrieved

14 March 2018

RxNorm ID

30121

1 reference

stated in

Global Substance Registration System

UNII

PJ0Y7AZB63

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

DrugBank ID

01171

1 reference

stated in

DrugBank

DrugBank ID

01171

language of work or name

English

title

Moclobemide (English)

retrieved

19 November 2016

Human Metabolome Database ID

HMDB0015302

0 references

UNII

PJ0Y7AZB63

1 reference

stated in

Global Substance Registration System

UNII

PJ0Y7AZB63

language of work or name

English

title

moclobemide (English)

retrieved

19 November 2016

PatientsLikeMe treatment ID

moclobemide

0 references

Probes And Drugs ID

PD003171

0 references

DrugCentral ID

1825

1 reference

stated in

UniChem

KEGG ID

D02561

1 reference

stated in

ChEBI

ChEBI ID

83531

language of work or name

English

title

moclobemide (English)

retrieved

3 October 2016

DeCS ID

34385

0 references

Freebase ID

/m/07j7nb

1 reference

stated in

Freebase Data Dumps

publication date

28 October 2013

Microsoft Academic ID

2780237459

0 references

OpenAlex ID

C2780237459

1 reference

stated in

OpenAlex

retrieved

26 January 2022

reference URL

https://docs.openalex.org/download-snapshot/snapshot-data-format

 

Sitelinks

Wikipedia(24 entries)

• afwiki Moklobemied
• arwiki موكلوبيميد
• azbwiki موکلوبماید
• dewiki Moclobemid
• enwiki Moclobemide
• eswiki Moclobemida
• fawiki موکلوبماید
• fiwiki Moklobemidi
• frwiki Moclobémide
• hrwiki Moklobemid
• huwiki Moklobemid
• itwiki Moclobemide
• lawiki Moclobemidum
• nlwiki Moclobemide
• plwiki Moklobemid
• ptwiki Moclobemida
• rowiki Moclobemidă
• ruwiki Моклобемид
• shwiki Moklobemid
• skwiki Moklobemid
• srwiki Moklobemid
• svwiki Moklobemid
• trwiki Moklobemid
• zhwiki 吗氯贝胺

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(1 entry)

• commonswiki Category:Moclobemide

Retrieved from "https://www.wikidata.org/w/index.php?title=Q421934&oldid=2025169791"